Jason Rudy is a seasoned commercial leader with over 20 years of experience in the interventional cardiology space.  He began his career at Radi Medical, which was later acquired by St. Jude Medical, where he played a central role in bringing the first coronary Optical Coherence Tomography (OCT) platform to market. Additionally, his career spans key commercial and leadership roles at Abbott, Biotronik, and most recently Philips.  Jason has led the launch of over 75 new and iterative devices in the coronary and structural heart markets globally.

Jason’s deep understanding of market development, physician engagement, and product positioning has helped drive the global adoption of innovative cardiovascular technologies. He is passionate about expanding access to best-in-class tools that enhance clinical outcomes and reduce procedural costs. Jason holds a Bachelor of Science in Management and an MBA in Leadership.